NEW YORK (GenomeWeb) – Med BioGene today announced that it is ready to initiate proceedings against its commercial partner Precision Therapeutics to enforce a C$1 million (US$920,000) milestone payment due to Med BioGene.
NEW YORK (GenomeWeb News) – Med BioGene today said that its commercial partner, Precision Therapeutics, has been certified to perform Med BioGene's lung cancer test out of Precision's Pittsburgh laboratory.
NEW YORK (GenomeWeb News) – Med BioGene today said that it and its commercial partner, Precision Therapeutics, have settled litigation with Signal Genetics and its Respira Health subsidiary, ending a dispute over an alleged breach of contract that began more than two years ago.
NEW YORK (GenomeWeb News) – Med BioGene had no revenues and a loss of $366,345, or breakeven on a per-share basis, for full-year 2012, the company disclosed in a document filed with Canadian regulators today.
NEW YORK (GenomeWeb News) – SynapDx this week said that it has received a "significant investment" from The Kraft Group that will support ongoing clinical development of its molecular diagnostic test for autism spectrum disorder.
NEW YORK (GenomeWeb News) – Syapse, a Palo Alto, Calif.-based startup developing software for interpreting next-generation sequencing data to diagnose and treat patients, has raised $3 million in Series A venture capital funding.